Access the full text.
Sign up today, get DeepDyve free for 14 days.
F. Wendling, E. Maraskovsky, N. Debili, C. Florindo, M. Teepe, M. Titeux, N. Methia, J. Breton‐Gorius, D. Cosman, W. Vainchenker (1994)
c-Mpl ligand is a humoral regulator of megakaryocytopoiesisNature, 369
C. Thompson (1985)
Selective consumption of large platelets during massive bleeding.British Medical Journal (Clinical research ed.), 291
T. Wong, L. Pedvis, M. Frojmovic (1989)
Platelet Size Affects both Micro- and Macro-Aggregation: Contributions of Platelet Number, Volume Fraction and Cell SurfaceThrombosis and Haemostasis, 62
P. Ridker, J. Manson, Julie Buring, J. Muller, C. Hennekens (1990)
Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physicians.Circulation, 82 3
J. Beer, L. Büchi, B. Steiner (1994)
Glycocalicin: a new assay--the normal plasma levels and its potential usefulness in selected diseases.Blood, 83 3
F. Sauvage, P. Hass, S. Spencer, B. Malloy, A. Gurney, S. Spencer, W. Darbonne, W. Henzel, Susan Wong, W. Kuang, K. Oles, B. Hultgren, L. Solberg, D. Goeddel, D. Eaton (1994)
Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligandNature, 369
C. Madden (1991)
Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease: The RISC Group Lancet 336: 827–830 Oct 1990Annals of Emergency Medicine, 20
J.R O'Brien (1990)
Shear-induced platelet aggregationThe Lancet, 335
W. Terres, P. Becker, A. Rosenberg (1994)
Changes in cardiovascular risk profile during the cessation of smoking.The American journal of medicine, 97 3
P. Bath (1993)
The Routine Measurement of Platelet Size Using Sodium Citrate Alone as the AnticoagulantThrombosis and Haemostasis, 70
R. Altman, L. Carreras, R. Diaz, E. Figueroa, E. Paolasso, J. Parodi, J. Cade, G. Donnan, M. Eadie, T. Gavaghan, E. OSullivan, D. Parkin, Renny Jtg., C. Silagy, H. Vinazzer, F. Zekert, H. Adriaensen, J. Bertrandhardy, M. Bran, J. David, J. Dricot, E. Lavennepardonge, R. Limet, A. Lowenthal, M. Moriau, S. Schapira, P. Smets, J. Symoens, R. Verhaeghe, M. Verstraete, A. Atallah, H. Barnett, R. Batista, J. Blakely, J. Cairns, R. Cote, J. Crouch, G. Evans, J. Findlay, M. Gent, Y. Langlois, J. Leclerc, J. Norris, G. Pineo, P. Powers, R. Roberts, L. Schwartz, J. Sicurella, W. Taylor, P. Théroux, A. Turpie, R. Weisel, J. Cui, L. Liu, J. Pirk, C. Bay, G. Boysen, J. Knudsen, P. Petersen, P. Sørensen, H. Tønnesen, P. Harjola, J. Arcan, B. Balkau, J. Blanchard, J. Boissel, B. Boneu, M. Bousser, M. Brochier, M. Cloarec, G. Cribier, M. Dechavanne, P. Drouin, E. Eschwège, B. Guiraudchaumeil, R. Hugonot, A. Leizorovicz, Y. Loria, L. Michat, J. Mirouze, E. Panak, J. Pasteyer, A. Rascol, L. Revol, M. Roy, J. Sellés, G. Slama, C. Starkman, M. Teule, N. Thibult, M. Verry, F. Albert, K. Andrassy, K. Breddin, R. Eckel, A. Encke, J. Frohlich, B. Hartung, H. Heiss, H. Hess, B. Hofling, D. Krause, G. Latta, H. Linke, D. Loew, R. Lorenz, K. Middleton, G. Novak, M. Oldendorf, N. Pfluger, D. Raithel, R. Reuter, G. Schettler, J. Schnitker, W. Schoop, H. Stiegler, K. Uberla, G. Vogel, M. Weber, I. Welbers, E. Zeitler, G. Arapakis, T. Chan, C. Mok, R. Szabó, N. Misra, K. Reddy, G. FitzGerald, A. Apollonio, F. Balsano, A. Basellini, L. Candelise, M. Catalano, N. Ciavarella, G. Ciuffetti, S. Coccheri, M. Cortellaro, G. Corvi, V. Coto, G. Davı̀, R. Decaterina, T. Diperri, C. Fieschi, R. Gentile, L. Gregoratti, P. Gresele, M. Lavezzari, A. Libretti, B. Magnani, Nenci Gg, G. Pagano, C. Patrono, L. Pedrini, M. Pini, P. Prandoni, F. Romeo, F. Rovelli, G. Rudelli, G. Ruvolo, G. Signorini, G. Tognoni, F. Violi, T. Fujimori, M. Kageyama, T. Katsumura, S. Kitamura, K. Maeda, A. Suzuki, H. Tohgi, S. Uchiyama, H. Utsumi, A. Garcia, A. Algra, Denottolander Gjh., Kupper Ajf., J. Vangijn, H. Hart, L. Kappelle, P. Koudstaal, T. Lemmens, J. Lodder, M. Pannebakker, P. Serruys, A. Vandenbelt, J. Vandermeer, A. Vandervijgh, Verheugt Fwa, G. Veth, J. Dale, K. Johannessen, E. Thaulow, P. Popescu, N. Tiberiu, Aznar Jrd., E. Esmatjes, P. Guiteras, J. Lasierra, P. Lopeztrigo, A. Oriol, L. Pomar, E. Rocha, F. Sanchez, J. Sanchorieger, G. Sanz, Berglund Ulf., C. Blomstrand, M. Boberg, M. Britton, C. Elwin, C. Helmers, J. Holm, L. Janzon, S. Juulmoller, H. Mulec, J. Olsson, S. Persson, G. Rasmanis, A. Rosén, K. Samuelsson, J. Soreff, N. Wahlgren, L. Wallentin, H. Baur, M. Bokslag, A. Bollinger, B. Meier, M. Pfisterer, C. Sitthiamorn, E. Acheson, P. Appleby, A. Asscher, A. Aukland, C. Baigent, S. Bala, A. Barnett, P. Bell, S. Bews, Born Gvr., J. Branagan, N. Brooks, M. Brown, N. Browse, R. Capildeo, M. Carmalt, A. Carter, I. Chalmers, M. Clarke, R. Clarke, Clyne Cac., R. Collins, Cooke, G. Coutts, D. Cove, P. Crowther, W. Cuthbertson, D. Debono, C. Dickerson, J. Dickinson, R. Doll, J. Dormandy, D. Dunbabin, S. Ell, P. Elphinstone, P. Elwood, V. Englishby, B. Farrell, C. Fiskerstrand, M. Flather, T. Foley, T. Foulds, K. Fox, P. Franks, H. Fraser, T. Gardecki, M. Gawel, A. Gent, A. Gershlick, J. Godwin, M. Goldman, C. Gray, D. Gray, R. Gray, H. Handoll, G. Hankey, Harrison Mjg., N. Henderson, S. Heptinstall, S. Hobbiger, E. Jones, Jones Nag., S. Jost, D. Julian, J. Kellett, R. Kester, G. Lowe, J. Mackenzie, C. McCollum, G. Mead, T. Meade, D. Mendelow, J. Miller, G. Morris, C. Nichol, M. Noble, Obrien, M. Ogier, S. Parish, M. Parry, R. Peto, J. Powell, P. Pozzilli, N. Qizilbash, A. Rahman, S. Rajah, D. Richards, S. Richards, R. Ripley, V. Roberts, F. Rose, Russell Rwr., P. Rubin, C. Ruckley, P. Sandercock, Shaw Mdm., K. Shaw, J. Shelley, J. Slattery, P. Sleight, S. Smith, P. Stewartlong, P. Sweetnam, Tansey Mjb., H. Tindall, J. Turney, H. Tyler, N. Varey, M. Vessey, M. Walker, M. Walker, C. Warlow, R. Wilcox, H. Willems, E. Wood, E. Wynjones, H. Adams, B. Barton, R. Bedford, B. Bick, S. Bingham, B. Brown, T. Bryant, J. Buring, C. Cabot, P. Canner, J. Chesebro, O. Chrisman, G. Clagett, J. Colwell, M. Dyken, D. Ellis, W. Fields, C. Furberg, V. Fuster, S. Goldman, J. Granett, R. Green, D. Green, R. Hardy, L. Harker, W. Harris, R. Hart, W. Hass, C. Hennekens, D. Hill, M. Hume, M. Igloe, G. Johnson, S. Jonas, G. Knatterud, T. Kohler, N. Lembo, D. Lewis, E. Lockhart, P. Majerus, Mcenany, R. McKenna, J. Mehta, J. Meyer, B. Molony, T. Moritz, D. Nicoloff, G. Nycz, H. Ono, G. Pantely, S. Phillips, P. Ridker, J. Robertson, R. Rothbart, E. Salzman, R. Sautter, R. Schlant, J. Schoenberger, M. Sengekontacket, G. Sharma, P. Steele, K. Steinnagel, J. Stratton, J. Sullivan, G. Timmis, J. Toole, Walker, S. Weisman, C. White, M. Wirecki, D. Wombolt, R. Wong, S. Yusuf, K. Zadina, D. Zucker (1994)
Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 308
G. Tofler, D. Brezinski, A. Schafer, C. Czeisler, J. Rutherford, S. Willich, R. Gleason, G. Williams, J. Muller (1987)
Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death.The New England journal of medicine, 317 27
J. McCarty, K. Sprugel, N. Fox, D. Sabath, K. Kaushansky (1995)
Murine thrombopoietin mRNA levels are modulated by platelet count.Blood, 86 10
John Martin, E. Trowbridge, G. Salmon, David Slater (1982)
The relationship between platelet and megakaryocyte volumes.Thrombosis research, 28 4
(1994)
Correction: Collaborative overview of randomised trials of Antiplatelet therapy - 1. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 308
The Group (1991)
Swedish Aspirin Low-dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic eventsThe Lancet, 338
JohnF. Martin, P. Bath, M. Burr (1991)
Influence of platelet size on outcome after myocardial infarctionThe Lancet, 338
C. Thompson, J. Jakubowski, P. Quinn, D. Deykin, C. Valeri (1984)
Platelet size and age determine platelet function independently.Blood, 63 6
Emilio D'Erasmo, G. Aliberti, F. Celi, E. Romagnoli, E. Vecci, Gianfranco Mazzuoli (1990)
Platelet count, mean platelet volume and their relation to prognosis in cerebral infarctionJournal of Internal Medicine, 227
J. Martin, E. Trowbridge, G. Salmon, Julie Plumb (1983)
The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration.Thrombosis research, 32 5
R. Emmons, D. Reid, R. Cohen, G. Meng, N. Young, C. Dunbar, N. Shulman (1996)
Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction.Blood, 87 10
The Group (1990)
Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery diseaseThe Lancet, 336
C. Patrono (1994)
Aspirin as an antiplatelet drug.The New England journal of medicine, 330 18
S. Karpatkin (1978)
Heterogeneity of human platelets. VI. Correlation of platelet function with platelet volume.Blood, 51 2
N. Maalej, J. Folts (1996)
Increased shear stress overcomes the antithrombotic platelet inhibitory effect of aspirin in stenosed dog coronary arteries.Circulation, 93 6
S. Lok, K. Kaushansky, R. Holly, J. Kuijper, C. Lofton-Day, P. Oort, F. Grant, M. Heipel, S. Burkhead, J. Kramer, L. Bell, C. Sprecher, H. Blumberg, Rebecca Johnson, D. Prunkard, A. Ching, S. Mathewes, M. Bailey, J. Forstrom, M. Buddle, S. Osborn, Simon Evans, P. Sheppard, Scott Presnell, P. O'hara, F. Hagen, G. Roth, D. Foster (1994)
Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivoNature, 369
Laurence Corash, Y. Mok, Jack Levin, G. Baker (1990)
Regulation of platelet heterogeneity: effects of thrombocytopenia on platelet volume and density.Experimental hematology, 18 3
K. Kaushansky, S. Lok, R. Holly, V. Broudy, N. Lin, M. Bailey, J. Forstrom, M. Buddle, P. Oort, F. Hagen, G. Roth, T. Papayannopoulou, D. Foster (1994)
Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietinNature, 369
K. Kaushansky (1995)
Thrombopoietin: the primary regulator of platelet production.Blood, 86 2
Platelet volume and total platelet mass are parameters of platelet activity and have become a prognostic factor in coronary heart disease. We have studied the influence of aspirin on platelet count, volume and total platelet mass in vitro and in a randomized double-blind, placebo-controlled study in 20 healthy young male volunteers in vivo. Aspirin had no influence in vitro on either platelet count, volume or mass. Repeated blood sampling during a 7-day treatment with 250 mg aspirin daily showed an increased platelet count (7.3% on day 1, 3.0% on day 2, 6.8% on day 4 and 9.3% on day 7; p < 0.01) and total platelet mass (7.2, 5.0, 8.6 and 11.5% on days 1, 2, 4 and 7, respectively, p < 0.01). Aspirin treatment without repeated blood withdrawal had no effect. These data indicate that aspirin may affect the circulating platelet mass under certain conditions.
Acta Haematologica – Karger
Published: May 1, 1999
Keywords: Aspirin; Glycocalicin; Platelets; Thrombopoietin
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.